"GLP-1 receptor agonists such as Ozempic have become increasingly popular for weight loss and diabetes management," Dr
TRT has also been associated with several other common adverse effects, some of which affect the cardiovascular system and include:27 28 Increased risk of atrial fibrillation, acute kidney injury, or pulmonary embolism Elevation of prostate-specific antigen Increased risk of prostate cancer Various lower urinary tract symptoms Sleep apnea Erythrocytosis If you decide to pursue TRT through Henry or most other providers, youll need to present certain test results to qualify for a prescription
Ozempic uses the active ingredient semaglutide, and Wegovy is the version approved for weight loss
doi: 10.1111/dom.13353 53 LingvayIHansenTMacuraSMarreMNauckMAde la RosaRet al
By mimicking this hormone, semaglutide drastically reduces appetite and caloric intake
Wegovy also has cardiovascular outcome data from the SELECT trial, which showed a 20% reduction in major cardiovascular events in people with obesity and established cardiovascular disease
